Mental Health of Parents Can Have Effect on Child

Government to compare Genentech's Lucentis to Avastin MarketWatch - The National Institutes of Health said Thursday that it will fund a study to compare two drugs by Genentech Inc. (DNA) used to treat the leading cause of blindness in the elderly.

US OKs new Merck drug for rare skin cancer Reuters.uk - By Lisa Richwine. WASHINGTON (Reuters) - Merck & Co Inc. won US approval for a new drug to treat a rare and slow-growing skin cancer, health officials said on Friday.